Table 2.
Evaluator # | Patient 1 | Patient 2 | |||
---|---|---|---|---|---|
Pre | Post | Pre | Post | ||
CSA (type I), mm2 (SD) | 1 | 0.0053 (0.00058) | 0.0073 (0.0004)* | 0.0061 (0.0008) | 0.0052 (0.0016) |
2 | 0.0060 (0.001) | 0.0077 (0.0003)* | 0.0067 (0.0017) | 0.0055 (0.0011) | |
CSA (type II), mm2 (SD) | 1 | 0.0084 (0.0011) | 0.0096 (0.0005) | 0.0067 (0.0005) | 0.0058 (0.0002)* |
2 | 0.0084 (0.0011) | 0.0101 (0.0004)* | 0.0067 (0.0005) | 0.0059 (0.0004)* | |
Proportion (type I), % (SD) | 1 | 57.3 (2.6) | 28.2 (1.8)* | 56.7 (5.8) | 52.3 (3.0) |
2 | 56.6 (2.8) | 28.7 (1.7)* | 57.0 (4.4) | 49.0 (7.6)* | |
Proportion (type II), % (SD) | 1 | 42.7 (2.6) | 71.8 (1.8)* | 43.3 (5.8) | 47.7 (3.0) |
2 | 43.4 (2.8) | 71.3 (1.7)* | 43.0 (4.4) | 51.0 (7.6)* | |
CNF proportion % (SD) | 1 | 4.77 (3.4) | 5.28 (3.4) | 7.14 (6.3) | 8.26 (2.9) |
2 | 2.18 (2.4) | 2.08 (1.7) | 6.3 (5.4) | 4.45 (1.5) | |
Neutrophil density, cells/mm3 (SD) | 1 | 218 (113) | 353 (125) | 445 (237) | 356 (164) |
2 | 445 (286) | 519 (244) | 633 (168) | 429 (170) | |
Macrophage density, cells/mm3 (SD) | 1 | 2852 (413) | 2642 (371) | 4347 (803) | 5158 (972) |
2 | 3855 (669) | 4273 (979) | 5846 (1555) | 7830 (501)* |
*Significant difference between pre- and post-training (p < 0.01)